Viewing Study NCT02283359


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-05-03 @ 8:03 PM
Study NCT ID: NCT02283359
Status: TERMINATED
Last Update Posted: 2016-01-15
First Post: 2014-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Cancer View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Distal Esophagus View
None Esophageal View
None Gastric View
None Carcinoma View
None Adenocarcinoma View
None Stomach View
None Gastro-esophageal junction View
None Recurrent View
None Metastatic View
None Unresectable View